Results 11 to 20 of about 263 (55)

Case Report: Maribavir for refractory cytomegalovirus viremia after renal transplantation in a child with Schimke's immune-osseous dysplasia. [PDF]

Front Immunol
Huang JS, Wang HK, Rong LP, Jiang XY, Liu LS, Huang LY, Zhang N, Yue ZH.   +7 more
europepmc   +1 more source

Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection. [PDF]

J Infect Dis, 2022
Chou S, Song K, Wu J, Bo T, Crumpacker C.   +4 more
europepmc   +1 more source

Use of Maribavir in Adult Patients With Post-Transplant Refractory Cytomegalovirus Infection in the Real-Life Setting. [PDF]

Transpl Int
Kamar N, Vuotto F, Cordonnier C, Gatault P, Saliba F, Couzi L, Bunel V, Lefevre C, Maric M, Ziad A, Alain S.   +10 more
europepmc   +1 more source

New Perspectives on Antimicrobial Agents: Maribavir. [PDF]

Antimicrob Agents Chemother, 2022
Halpern-Cohen V, Blumberg EA.
europepmc   +1 more source

Optimizing maribavir management: The role of health system specialty pharmacies in access, monitoring, and waste reduction. [PDF]

J Manag Care Spec Pharm
Donald DR, Zuckerman AD, Dee K, Gargurevich N, Choi L, Oboh S, Renfro CP.   +6 more
europepmc   +1 more source

Unraveling Cytomegalovirus Drug Resistance in Transplant Patients by Targeting Deep Sequencing. [PDF]

J Med Virol
Alemán S, Camacho J, Recio V, Ruiz E, Zamarrón P, Anel J, Enjuto M, Tarragó D.   +7 more
europepmc   +1 more source

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial. [PDF]

Clin Infect Dis, 2022
Avery RK, Alain S, Alexander BD, Blumberg EA, Chemaly RF, Cordonnier C, Duarte RF, Florescu DF, Kamar N, Kumar D, Maertens J, Marty FM, Papanicolaou GA, Silveira FP, Witzke O, Wu J, Sundberg AK, Fournier M, SOLSTICE Trial Investigators.   +18 more
europepmc   +1 more source

Generation of a panel of mutants that are resistant to standard of care therapies in a clinically relevant strain of human cytomegalovirus for drug resistance profiling. [PDF]

Antiviral Res
Carter MF, Knight K, Kayode Y, Murphy EA.   +3 more
europepmc   +1 more source

Interplay of Belatacept Immunosuppression and Maribavir Antiviral Activity in Recurrent CMV Viremia: Clinical Implications and Literature Review. [PDF]

Viruses
Gani I, Mirza A, Baig U.
europepmc   +1 more source

Real-World Use of Letermovir and Maribavir for CMV Prophylaxis and Treatment in Solid Organ Transplant Recipients: Clinical Outcomes and Resistance Patterns From a Dual-Center Cohort. [PDF]

Pharmacotherapy
Xu MT, Wright A, Mah A, Matic N, Lowe C, Hong C, Belga S, Tsai WP.   +7 more
europepmc   +1 more source